Results 181 to 190 of about 82,628 (226)

CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21. [PDF]

Front Immunol
Bahng I.
europepmc   +1 more source

Enhanced cleavage of genomic <i>CCR5</i> using CASX2^Max. [PDF]

RNA Biol
Hodge CA, Donegan NP, Armstrong DA, Hayden MS, Howell AL.   +4 more
europepmc   +1 more source

Chemokine Networks in Cutaneous T Cell Lymphoma: Tumor Microenvironment Remodeling and Therapeutic Targets. [PDF]

Curr Issues Mol Biol
Yu Z, Li F, Quan Y, Hu W, Zhang P, Xie X.   +5 more
europepmc   +1 more source

ANGPTL8 links refeeding to monocyte dynamics and metabolic inflammation via the CCL5-CCR5 axis. [PDF]

JCI Insight
Kan RR, Wang SY, Meng XY, Huang L, Xiang YX, Mao BB, Zou HJ, Guo YM, Pan LM, Luo PQ, Yang Y, Liu ZL, Ma DL, Li WJ, Chen Y, Li DP, Yu XF.   +16 more
europepmc   +1 more source

N-terminal protein-macrocycles enabled by conjugate addition/ring expansion cascade reactions. [PDF]

Chem Sci
Hughes OR, Tufail A, Hutton E, Nabarro J, Howarth R, Yates ND, Whitwood AC, Robson CN, Signoret N, Fascione MA, Spicer CD, Unsworth WP.   +11 more
europepmc   +1 more source

The role of chemokines and their receptors in cardiovascular diseases. [PDF]

Front Immunol
Srikanth S, DeVito L, Constantinesco NJ, Gopal R.   +3 more
europepmc   +1 more source

Gastrointestinal Mucosal Disruptions During ART-Treated SIV<i>/Plasmodium fragile</i> Co-Infection. [PDF]

Pathog Immun
Nemphos SM, Green HC, Prusak JE, Fell SL, Midkiff C, Rodgers A, Perret J, Goff K, Miller J, Varnado M, Didier K, Valencia N, Moström MJ, Tatum C, Barnes MB, Krzykwa CE, Rowe LA, Allers C, Grasperge B, De Paris K, Maness NJ, Kaur A, Londono-Renteria B, Blair RV, Manuzak JA.   +24 more
europepmc   +1 more source

Unveiling the Role of CCL3: A Driver of CIPN in Colon Cancer Patients? [PDF]

Biomedicines
Luzac I, Regalado CR, Balogh M.
europepmc   +1 more source

Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer. [PDF]

J Exp Clin Cancer Res
Liu B, Zhang W, Ji Y, Wu J, Su R, Liu X, Li A, Shen K, Chai X, Wu H, Ma Z, Hu C, Jiang Z, Dong L, Zhu Y, Dong B, Xue W, Pan J, Wang Q.   +18 more
europepmc   +1 more source